DAIICHI SANKYO COMPANY, LIMITED : Daiichi Sankyo Appoints New Group Corporate Officers

For Immediate Release

2014.03.03

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, President and CEO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Corporate Officer,
Vice President, Corporate Communications Department
Telephone: [phone]
http://www.daiichisankyo.com/

Daiichi Sankyo Appoints New Group Corporate Officers

Tokyo, Japan (March 3, 2014) - Daiichi Sankyo Company, Limited today announced the appointment of new Group corporate officers effective from April 1, 2014.

1. DAIICHI SANKYO CO., LTD.

New Position	Name	Current Position
Representative Director, President and CEO	Joji Nakayama	Representative Director, President and CEO and President of Japan Company
Member of the Board, Executive Vice President, Head of Supply Chain Division and Legal Affairs & CSR Division and General Affairs & Human Resources Division	Yuki Sato	Member of the Board, Senior Executive Officer, Head of Supply Chain Division and Legal Affairs & CSR Division
Member of the Board, Executive Vice President, Head of Corporate Management Division	Manabu Sakai	Member of the Board, Senior Executive Officer, Head of Corporate Management Division
Member of the Board, Senior Executive Officer, Head of Vaccine Business Intelligence Division	Takeshi Ogita	Member of the Board, Senior Executive Officer, Head of General Affairs & Human Resources Division and Vaccine Business Intelligence Division, Japan Company
Member of the Board, Senior Executive Officer, Head of Corporate Strategy Division	Kazunori Hirokawa	Member of the Board, Senior Executive Officer, Head of Corporate Strategy Division and Business Intelligence Division, Japan Company
Executive Officer, President of Japan Company and Head of Business Intelligence Division, Japan Company	Sunao Manabe	Corporate Officer, Vice President of Corporate Strategy Department, Corporate Strategy Division
Executive Officer, Vice President of Corporate Strategy Department, Corporate Strategy Division	Toshiaki Sai	Corporate Officer, Vice President of Global Brand Strategy Department, Corporate Strategy Division
Executive Officer, Head of Pharmaceutical Technology Division	Katsumi Fujimoto	Corporate Officer, Head of Pharmaceutical Technology Division
Executive Officer, Head of Quality and Safety Management Division	Toshiaki Tojo	Corporate Officer, Head of Quality and Safety Management Division
Corporate Officer, Vice President of Secretariat Department, General Affairs & Human Resources Division	Ryoji Nagasaka	Corporate Officer, Vice President of Kyushu Branch, Sales & Marketing Division, Japan Company
Corporate Officer, Vice President of Intellectual Property Department, Corporate Strategy Division	Kazuo Sato	Corporate Officer, Vice President of Business Development & Licensing Department, Corporate Strategy Division

New Position	Name	Current Position
Corporate Officer, Vice President of External Affairs Department, Business Intelligence Division, Japan Company	Kazuyuki Watanabe	Vice President of External Affairs Department, Business Intelligence Division, Japan Company
Corporate Officer, Vice President of Japan Development Oversight Function, R&D Division	Kohei Wada	Vice President of Global Project Management Department, R&D Division
Corporate Officer, Head of Sales & Marketing Divsion and Vice President of Marketing Department, Japan Company	Satoru Kimura	Vice President of Kyoto Branch , Sales & Marketing Division, Japan Company
Corporate Officer, Vice President of Research Oversight Function, R&D Division	Masahiko Ohtsuki	Vice President of Research Oversight Function, R&D Division

◇Takeshi Ogita (current Member of the Board, Senior Executive Officer) will be additionally appointed Representative Director and President of Kitasato Daiichi Sankyo Vaccine Co., Ltd. as of April 1st, 2014.

◇Ryoichi Kibushi (current Senior Executive Officer) will become Corporate Advisor as of April 1st, 2014.

◇Tomoo Yokoi (current Executive Officer) will become Corporate Advisor as of April 1st, 2014.

◇Katsuaki Miyoshi (current Corporate Officer) will be appointed Member of the Board and Executive Vice President of Daiichi Sankyo Business Associe Co., Ltd. as of April 1st, 2014.

◇Satoshi Kunitada (current Corporate Officer) will be appointed Member of the Board and Executive Vice President of Daiichi Sankyo RD Novare Co., Ltd. as of April 1st, 2014.

【Management structure as of April 1st, 2014】

Position	Name	Responsibilities
Representative Director, Chairman	Takashi Shoda
Representative Director, President and CEO	Joji Nakayama
Member of the Board, Executive Vice President	Yuki Sato	Head of Supply Chain Division and Legal Affairs & CSR Division and General Affairs & Human Resources Division
	Manabu Sakai	Head of Corporate Management Division
Member of the Board, Senior Executive Officer	Takeshi Ogita	Head of Vaccine Business Intelligence Division
	Kazunori Hirokawa	Head of Corporate Strategy Division
Member of the Board (Outside)	Hiroshi Hirabayashi
	Kunio Ishihara
	Ichiro Kanazawa
	Seiji Sugiyama

Position	Name	Responsibilities
Member of the Audit and Supervisory Board	Kazuo Koike
	Takashi Chiba
Member of the Audit and Supervisory Board (Outside)	Akio Yamada
	Shigeaki Ishikawa
Senior Executive Officer	Glenn Gormley	Head of R&D Division
Executive Officer	Shuji Handa	President of ASCA Company
	Sunao Manabe	President of Japan Company and Head of Business Intelligence Division, Japan Company
	Toshiaki Sai	Vice President of Corporate Strategy Department, Corporate Strategy Division
	Katsumi Fujimoto	Head of Pharmaceutical Technology Division
	Toshiaki Tojo	Head of Quality and Safety Management Division
Corporate Officer	Noriaki Ishida	Vice President of Corporate Communications Department, Corporate Management Division
	Shinichi Terano	Vice President of Tokyo Branch, Sales & Marketing Division, Japan Company
	Ryoji Nagasaka	Vice President of Secretariat Department, General Affairs & Human Resources Division
	Junichi Koga	Vice President of Biologics Oversight Function, R&D Division
	Koichi Akahane	Vice President of R&D Planning Department, R&D Division
	Kenji Inoue	Vice President of Osaka Branch, Sales & Marketing Division, Japan Company
	Kazuo Sato	Vice President of Intellectual Property Department, Corporate Strategy Division
	Norimasa Kamura	Vice President of Human Resources Department, General Affairs & Human Resources Division
	Kazuyuki Watanabe	Vice President of External Affairs Department, Business Intelligence Division, Japan Company
	Kohei Wada	Vice President of Japan Development Oversight Function, R&D Division
	Satoru Kimura	Head of Sales & Marketing Division and Vice President of Marketing Department, Japan Company
	Masahiko Ohtsuki	Vice President of Research Oversight Function, R&D Division

2．DAIICHI SANKYO HEALTHCARE CO., LTD.

New Position	Name	Current Position
Member of the Board, Executive Officer, in charge of Corporate Planning & Corporate Administration	Katsuhiko Yoshida	Member of the Board, Executive Officer, Vice president of Corporate Planning Department
Member of the Board, Corporate Officer, Vice President of Sales Administration Department	Yasuhiro Kawanaka	Member of the Board, Corporate Officer, Head of Sales Division

3．KITASATO DAIICHI SANKYO VACCINE CO., LTD.

New Position	Name	Current Position
President （Concurrently serve as: Member of the Board, Senior Executive Officer, Head of Vaccine Business Intelligence Division, Daiichi Sankyo Co.,Ltd）	Takeshi Ogita	Member of the Audit and Supervisory Board（Outside）
Executive Vice President	Haruhisa Kubota	Executive Vice President and Head of Development Research Division

◇Takeshi Ogita will concurrently serve as Member of the Board, Senior Executive Officer, Head of Vaccine Business Intelligence Division, Daiichi Sankyo Co.,Ltd after April 1st, 2014.

◇Masahiro Okabe (current President） will retire on March 31st, 2014.